May 21, 2024 / 07:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the J.B. Pharma's Q4 FY24 earnings conference call as on May 21, 2024. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Jason D'souza, Executive Vice President at J.B. Pharma. Thank you, and over to you, sir.
Jason D'souza - J B Chemicals and Pharmaceuticals Ltd - EVP
Thank you, Dorwin. Welcome to the earnings call of J.B. Pharma. We have with us today, Nikhil Chopra, CEO and Whole Time Director; Kunal Khanna, President, Operations; and Narayan Saraf, the CFO at J.B. Chemicals & Pharmaceuticals Limited.
Before we begin, I would like to state that some of the statements in today's discussion may be forward-looking in nature and may involve certain risks and uncertainties. A detailed statement in this regard is available in the Q4 results presentation that has been sent to you earlier. I would like to now hand over the floor to Mr. Nikhil Chopra to begin the proceedings for the call and give us his opening comments
Q4 2024 J B Chemicals and Pharmaceuticals Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot